Zhengye Biotechnology Holding (ZYBT) Work In Process (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Work In Process for 3 consecutive years, with $2.5 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Work In Process fell 45.8% year-over-year to $2.5 million in Q4 2025; TTM through Dec 2025 was $2.5 million, a 45.8% decrease from a year earlier, with the FY2025 full-year figure at $2.5 million, down 44.15% from the prior year.
• Work In Process was $2.5 million for Q4 2025 at Zhengye Biotechnology Holding, down from $4.6 million in the prior quarter.
• Over five years, Work In Process peaked at $4.7 million in Q4 2023 and troughed at $2.5 million in Q4 2025.
• A 3-year average of $3.9 million and a median of $4.6 million in 2024 frame the typical range for Work In Process.
• Across the five-year window, Work In Process decreased 1.31% in 2024 and plunged 45.8% in 2025, its largest moves.
• Over 3 years, Work In Process stood at $4.7 million in 2023, then retreated by 1.31% to $4.6 million in 2024, then sank by 45.8% to $2.5 million in 2025.
• The last three Work In Process figures came in at $2.5 million (Q4 2025), $4.6 million (Q4 2024), and $4.7 million (Q4 2023), per Business Quant data.